Stemnion, Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
20
Ending by 2030
Nov 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 21, 2027The maintenance fee for Methods of treating spinal cord injury and minimizing scarring (US 9,084,787) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Mar 22, 2027The maintenance fee for Methods for modulating immune responses (US 9,138,443) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 3 fees due May 3 to 17, 2027 · next May 3
- 1 fee due Jun 29, 2027The maintenance fee for Medical device (US 9,220,817) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Methods for treating cartilage disorders, diseases, and injuries (US 9,314,487) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,084,787 | Methods of treating spinal cord injury and minimizing scarring In force · From the USPTO record | In force | From the USPTO record | |
| US 8,506,949 | Methods for modulating inflammatory and/or immune responses In force · From the USPTO record | In force | From the USPTO record | |
| US 8,647,617 | Methods for modulating inflammatory and/or immune responses In force · From the USPTO record | In force | From the USPTO record | |
| US 9,173,908 | Methods for modulating immune responses In force · From the USPTO record | In force | From the USPTO record | |
| US 9,138,443 | Methods for modulating immune responses In force · From the USPTO record | In force | From the USPTO record | |
| US 8,475,788 | Methods of treating spinal cord injury and minimizing scarring In force · From the USPTO record | In force | From the USPTO record | |
| US 8,197,804 | Methods for treating nervous system injury and disease In force · From the USPTO record | In force | From the USPTO record | |
| US 8,808,753 | Methods for treating pustular psoriasis In force · From the USPTO record | In force | From the USPTO record | |
| US 8,058,066 | Cellular factor-containing solution compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,088,732 | Compositions comprising physiologic concentrations of cytokines In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 39: 1 patent in force now held by others · 7 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 25 no status recorded